Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations
Accessed on April 11, 2024.
Lixisenatide Monotherapy GetGoal-Mono was a 12-week, double-blind, placebo-controlled trial that randomised 361 patients with type 2 diabetes of mean duration 1.11.4 years attempting to control their diabetes with diet and exercise alone, to lixisenatide OD for 12 weeks as a one-step dose increase (10 g for 2 weeks, then 20 g) or two-step dose increase (10 g for 1 week, 15 g for 1 week, then 20 g), or placebo also with a one- or two-step increase [17]
Can GLOW be used for injuries
HDL cholesterol may initially decrease during active weight loss but generally increases with weight maintenance
Originally developed to help regulate blood sugar levels in individuals with type 2 diabetes, semaglutide has recently gained FDA approval for weight management as well